Pediatric Influenza Vaccine Update: Does Technology Make a Difference?
This activity is supported by an educational grant from Seqirus USA Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Seqirus USA Inc.
Activity Description
Influenza severity in children can range from uncomplicated self-limited illness to severe disease and death. High influenza infection rates in the pediatric population contribute to the spread of the virus in the wider community. Because immunization is the most effective means of prevention, it is critical that clinicians have robust knowledge regarding available influenza vaccines, differences among them, and data supporting their use. In this CE activity, expert clinicians will compare influenza vaccines based upon their efficacy, dosage and administration, and indications in children. Faculty will summarize differences between influenza vaccine technologies, review real-world efficacy findings, and discuss strategies to improve pediatric vaccination rates.
Target Audience
The intended audience for this activity is pediatricians, family medicine physicians, general practice physicians, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of pediatric patients at risk for influenza.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Incorporate the use of influenza vaccines into practice based upon their efficacy, technology, dosage and administration, and application in the pediatric population.
- Summarize the differences among egg-based inactivated, cell culture–based inactivated, and live-attenuated influenza vaccines.
- Apply real-world clinical findings into practice regarding the efficacy of pediatric influenza vaccines and how vaccination rates can be improved.
Activity Co-Chairs
Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP, FAAN
Executive Director
Carrico and Ramirez, PLLC
Professor, Gratis
Division of Infectious Diseases
University of Louisville
School of Medicine
Louisville, KY
Charles P. Vega, MD, FAAFP
Health Sciences Clinical Professor,
Department of Family Medicine
Director, Program in Medical Education
for the Latino Community
Assistant Dean for Culture and
Community Education
University of California, Irvine
Irvine, CA
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is approved for 0.75 contact hour(s) of continuing education (which includes 0.75 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 23106403. This activity was planned in accordance with AANP Accreditation Standards and Policies.
American Academy of Physician Associates (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME. PAs may receive a maximum of 0.75 credit hours for completing this program.
This enduring material is approved for 1 year from the date of original release, October 31, 2023, to October 30, 2024
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate or Contact Hour Certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Co-Chairs report the following relevant financial relationship(s)
Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP, FAAN
Advisor: Moderna, Novavax, Pfizer, Seqirus, Valneva
Consultant: Valneva
Speaker Contracted by Ineligible Company: Pfizer, Sanofi
Charles P. Vega, MD, FAAFP
Consultant: Boehringer Ingelheim, GSK, Johnson & Johnson
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this lecture is available upon request. Requests should include the activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CE Questions?
Contact us at cme@vindicoCME.com